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Introduction
In the treatment of obesity many natural compounds whose activity is based on the capacity to absorb dietary factors are currently used. In addition to slimming drugs, patients can choose from a wide range of dietary supplements available over the counter.
On the market, there are many preparations containing hydrophilic fibres, such as glucomannan, xanthine, psyllium, agar-agar and pectin and chitosan. The mechanism of action of these dietary supplements is to increase their volume by absorbing water and filling the stomach. The result is increased satiety by coating the walls of the upper gastrointestinal tract, which hinders the absorption of glucose [1, 2] . In the intestinal transit, a polymer gel is produced. which has the ability to adsorb nutrients [3, 4] .
There are no reported studies in the available literature on the relationship between the level of adsorption of simvastatin and the type of chitosan polymer used. The adsorption properties of chitosan may lead to a significant interaction with the active substances of the medication taken by patients. The intensity of the adsorption phenomenon may also depend on the type of chitosan and its properties.
The aim of the study was to investigate the in vitro effect of selected physicochemical factors on the ability of adsorption of various kinds of chitosans. Moreover, an assessment of the assumption that the use of formulations of chitosan is important for bioavailability of the drug substance to be administered orally was made. Finally, the study aimed to clarify the mechanism of interaction of the drug simvastatin with dietary supplements, which contains chitosan. A high adsorption capacity of the chitosan polymer may reduce the bioavailability of the drugs.
Materials and method

Materials
Chitosan
Chitosan is a deacetylated chitin, i.e. a product obtained after the removal of functional acetyl groups. The greater the degree of deacetylation, the higher the functional effect (biochemical activity) of the preparation. It occurs in the form of cations (positively charged ions) and has a high degree of deacetylation (over 85%), giving the highest functional effect. The polycationic behaviour of chitosan, resulting from the presence of protonated amino groups enables the formation of multicomplexes with derivatives carrying negative charges, such as polymers or proteins. In addition, chitosan is capable of selectively attaching to a molecule of cholesterol, fat, tumour cells, nucleic acids (DNA and RNA) [5, 6] .
In the present study, natural chitosans with a very high degree of deacetylation, in a range between 85% and 95%, were used (Table 1) . Chitosan was treated with IR radiation before use to produce smaller molecular weight. During the test, a radiation dose from 5 to 30 kGy was applied. 
Simvastatin
Simvastatin (lat. Simvastatinum) is a multifunctional organic compound, a natural derivative of lovastatin, a prodrug with a molecular structure of a lactone ring, which is hydrolysed to be common with other statins with active pharmacophoric groups -chain β-hydroxycarboxylic acid. It is used as a drug, and its lipid-lowering effect has additional pleiotropic effects on the cardiovascular system through effects on endothelial function, stabilising atherosclerotic plaques, inhibiting coagulation, stimulating the fibrinolysis system and inhibiting inflammatory and immunomodulatory effects. It works by inhibiting the enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. 
Method 2.2.1. Investigation of Simvastatin adsorption process on the chitosans probes
The adsorption of simvastatin was analysed by a static-dynamic method in the concentration range of generally ingested single doses, using a pharmaceutical model of the gastrointestinal tract based on the modification of Polish Pharmacopoeia test [7] [8] [9] [10] [11] .
The study was conducted in a shaking water bath, maintaining conditions to closely resemble those in the gastrointestinal tract, with an amplitude of vibration imitating peristaltic movements (300 rpm) and the process temperature (37°C).
For centrifugation, 2 ml of the appropriate solutions of chitosan was dispensed into 5 ml vials and the pH was adjusted to 2 (0.05 M HCl), which is suitable for fasting gastric pH. The volume of solution used corresponded to 0.03 g chitosan (the dose used as a slimming supplement). Then, into 5 ml vials, an amount of medicinal substance corresponding to 0.125 g of simvastatin (dose in therapeutic treatments) was added and shaken (300 rpm) for 2 hours. The contents of test tubes were then adjusted with 0.1 M Na 2 CO 3 to pH 7.0-7.6, which corresponds to the pH of the intestinal tract and colon. Samples were incubated at 37°C with shaking (300 rpm) for 2.5 hours.
The tested system was brought to room temperature and centrifuged in a centrifuge (2100x g) for 20 minutes and was then allowed to stabilise for 0.5 hours. Subsequently, 1.5 ml of the supernatant was collected in clear tubes and spectrophotometrically determined (λ = nm) in 1 cm quartz cuvettes and using a standard curve determined from the concentration of the determined drug.
Results and discussion
The impact of intrinsic viscosities and viscosity-average molecular weights for
the the adsorption of simvastatin on chitosans Analysis of the effect of the radiation dose degradation that affects the viscosity of the material obtained for the simvastatin adsorption capacity on chitosans shows that the reduction in the intrinsic viscosity of chitosan increases the quantity of the bound drug (Table 2 and Fig. 2 onto chitosan in the pH ranges used, and the binding ability of chitosan varies with type and its degradation The results of the measurement of the adsorption process of simvastatin by chitosan contained in the preparations used, generally available over the counter as dietary supplements, confirmed the hypothesis that the adsorption would have wide variations for individual preparations. Simvastatin is bound in preparations containing chitosans with an intrinsic viscosity between 0.14 and 0.34 (dm ). The binding of simvastatin by the various dietary supplements showed similar values, but was much higher in comparison with the adsorption of the drug by the various manufacturers of chitosans. Chitosan contained in the drug formulations has the ability to bind almost 95% of the administered dose of the drug, which significantly affected the bioavailability of simvastatin used.
The fact that the lowest value of the adsorption at pH 6.4 can be explained by the chemical properties of chitosan whose cationic character was shown only at pH >6.7, and this may have electrostatic voltage and an ability to demonstrate adsorption in relation to medicinal substances [12] .
At a pH above 7.6 (pH of the intestines filled with ingesta), the average adsorption at the highest dose of the drug on chitosan was in the range of 27.0% to 95.0%.
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Conclusion
In the available literature, there are many reports regarding the study of chitosan adsorption properties and the potential for using chitosan as a carrier of active substances. However, there are no studies on the interaction of preparations containing different chitosan variants with the active substances of the simultaneously concomitant drugs [13, 14] .
The growth of the adsorption of simvastatin on the polymer with increasing pH from 7.6 to 8.0 can be explained by the swelling properties of chitosan, which forms a conglomerate present in the form of an emulsion system.
On the basis of the above considerations, it can be concluded that between the tested drug and polymer is an antagonistic interaction, consisting of the adsorption of the drug on the chitosan polymer, which reduces the drug's bioavailability and therapeutic concentration.
